High-Dose Folic Acid Pretreatment Blunts Cardiac Dysfunction During Ischemia Coupled to Maintenance of High-Energy Phosphates and Reduces Postreperfusion Injury
Circulation Moens et al.
10.1161/CIRCULATIONAHA.107.725481
Correction
In the version of the article, "High-Dose Folic Acid Pretreatment Blunts Cardiac Dysfunction During Ischemia Coupled to Maintenance of High-Energy Phosphates and Reduces Postreperfusion Injury" by Moens et al that published ahead of print on March 24, 2008 (DOI: 10.1161/CIRCULATIONAHA.107.725481), several errors needed correcting.
1. On page 1812, the following abbreviations should have been defined in the legend to Figure 1: End diast. indicates end-diastolic; Tau, time
constant of relaxation.
2. On page 1812, first paragraph of the Results section, line 8, "Figure 1A, bottom" should read, "Figure 1A, top."
3. On page 1812, first paragraph of the Results section, line 10, "Figure 1A, top" should read, "Figure 1A, bottom."
4. On page 1814, the following sentence should have been inserted into the legend of Figure 3: "Redox state reflected by the reduced/oxidized glutathione ratio (GHS/GSSG) and malondialdehyde changed markedly with ischemia but was unaltered by FA treatment.
These changes have been made to the print and current online versions of the article. The authors regret these errors.